Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4-Reference-Cited by-同舟云学术

Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4

Published:2021-07 Issue: Volume:335 Page:117-129
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Pallarès Victor,Núñez Yáiza,Sánchez-García Laura,Falgàs Aïda,Serna Naroa,Unzueta Ugutz,Gallardo Alberto,Alba-Castellón Lorena,Álamo Patricia,Sierra Jorge,Villaverde Antonio,Vázquez Esther,Casanova Isolda,Mangues Ramon

Funder

AGAUR

Generalitat de Catalunya

European Commission

Agencia Estatal de Investigación

Cellex Foundation

Generalitat de Catalunya Departament de Salut

ICREA

ISCIII

CIBER-BBN

Fundacio la Marato de TV3

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference48 articles.

1. Acute myeloid leukemia: 2019 update on risk-stratification and management;Estey;Am. J. Hematol.,2018

2. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Döhner;Blood.,2017

3. An update of current treatments for adult acute myeloid leukemia;Dombret;Blood.,2016

4. Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside;Cho;Korean J. Intern. Med.,2017

5. Role of CXCR4 in the pathogenesis of acute myeloid leukemia;Peled;Theranostics.,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacterial nanotechnology as a paradigm in targeted cancer therapeutic delivery and immunotherapy;Microsystems & Nanoengineering;2024-08-20

2. Unveiling G-protein coupled receptors as potential targets for ovarian cancer nanomedicines: from RNA sequencing data analysis to in vitro validation;Journal of Ovarian Research;2024-07-27

3. Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia;Small;2024-06-27

4. CXCR4-Mediated Codelivery of FLT3 and BCL-2 Inhibitors for Enhanced Targeted Combination Therapy of FLT3-ITD Acute Myeloid Leukemia;Biomacromolecules;2024-06-13

5. Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice;International Journal of Molecular Sciences;2024-02-01